Bufalin Targets STK33 to Suppress Triple-Negative Breast Can
2026-06-03
The reference study identifies Serine/Threonine Kinase 33 (STK33) as a critical target of Bufalin in triple-negative breast cancer (TNBC), revealing that Bufalin directly binds and degrades STK33 to inhibit tumor progression. These findings clarify Bufalin’s molecular mechanism and provide a foundation for targeted TNBC therapy development.
Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit
2026-06-02
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of resolving small proteins and peptides (1–10 kDa), which are poorly separated by conventional Tris-glycine SDS-PAGE. This kit is suitable for research workflows focused on low molecular weight protein and peptide analysis, but is not intended for diagnostic or clinical use.
SB743921: Kinesin Spindle Protein Inhibitor for Cancer Assay
2026-06-02
SB743921, a potent and selective kinesin spindle protein inhibitor, enables precision control of mitotic arrest and apoptosis in cancer research workflows. This article translates recent methodological advances and troubleshooting strategies into actionable protocols, ensuring data reliability and reproducibility in both in vitro and xenograft models.
Virus-Mimicking Particles Enable Targeted Extrahepatic mRNA
2026-06-01
This study introduces a biomimetic, self-assembling enveloped virus-mimicking particle (EVMP) platform for delivering mRNA to extrahepatic organs with high efficiency and safety. The research demonstrates the ability to overcome the hepatic tropism of traditional delivery systems, significantly expanding the therapeutic possibilities for mRNA-based immunotherapies.
2,7-Dichlorodihydrofluorescein Diacetate for Advanced ROS De
2026-06-01
2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) empowers precise detection of intracellular ROS across fluorescence microscopy, flow cytometry, and plate-based assays. Recent research underscores its critical role in elucidating oxidative stress mechanisms in disease models, with practical protocol enhancements boosting sensitivity and reproducibility.
IGF2BP1 Drives Pulmonary Fibrosis via Macrophage Metabolic R
2026-05-31
This study reveals that the m6A reader IGF2BP1 exacerbates pulmonary fibrosis by stabilizing THBS1 mRNA, which promotes M2 macrophage polarization and glycolytic activation through a TLR4-dependent mechanism. These insights illuminate a novel regulatory axis in fibrosis pathogenesis and highlight potential targets for future therapeutic intervention.
Capecitabine in Advanced Tumor-Stroma Models: Applied Protoc
2026-05-30
Capecitabine (N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine) enables precise, tumor-selective chemotherapy modeling in complex assembloid systems. This guide details experimental workflows, troubleshooting strategies, and protocol innovations—empowering researchers to harness Capecitabine for next-generation tumor-targeted drug delivery and apoptosis assays.
CCR7–Notch1 Crosstalk Maintains Stemness in Mammary Cancer C
2026-05-29
Boyle et al. (2017) elucidate a mechanistic link between CCR7 and Notch1 signaling in maintaining cancer stem-like cells within mammary tumors. Their findings reveal that CCR7 activation potentiates Notch1 pathway activity, promoting tumor cell stemness and suggesting a rationale for dual-targeted therapeutic interventions.
Bestatin (Ubenimex) in Applied Aminopeptidase & MDR Research
2026-05-29
Bestatin (Ubenimex) distinguishes itself as a highly selective aminopeptidase inhibitor, enabling advanced workflows in apoptosis, multidrug resistance, and jasmonate signaling studies. This article delivers actionable protocols, troubleshooting insights, and cross-domain perspectives for researchers leveraging APExBIO’s Bestatin in translational bench research.
Practical Guide to EDC.HCl (3-(ethyliminomethylideneamino)-N
2026-05-28
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent that streamlines amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is designed for in vitro applications and is not validated for in vivo or clinical use.
CA-074 Me in Lysosomal Membrane Permeabilization Assays
2026-05-28
Explore how CA-074 Me, a potent cathepsin B inhibitor, enables advanced dissection of lysosomal membrane permeabilization and necroptosis mechanisms. This article provides protocol insights, practical assay guidance, and original interpretation of recent mechanistic breakthroughs.
Multianimal MRI Protocols Advance Tumor Monitoring in KPC Mo
2026-05-27
Kempinska et al. introduce a multianimal MRI protocol enabling simultaneous, high-resolution imaging of up to four mice in genetically engineered pancreatic cancer models. This advance streamlines longitudinal tumor monitoring and facilitates rigorous evaluation of chemotherapeutic response, with implications for optimizing preclinical trial design.
RNA Clean and Concentrator Kit: High-Throughput RNA Purifica
2026-05-27
The RNA Clean and Concentrator Kit empowers researchers to achieve rapid, high-yield RNA purification from enzymatic reactions, streamlining workflows for single- and double-stranded RNA. Its spin column format delivers reproducibility and purity crucial for molecular biology, with proven success in advanced disease modeling and transcriptomics.
Recombinant Human Oncostatin M: Precision Tools for Translat
2026-05-26
Explore how Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) empowers the next generation of translational research, bridging mechanistic cytokine biology and strategic assay design. This article delivers actionable protocol guidance, competitive positioning, and a critical outlook on leveraging OSM for disease modeling and therapeutic innovation.
SD 169 (Indole-5-carboxamide): Redefining p38 MAPK Inhibitio
2026-05-26
Explore how SD 169 (indole-5-carboxamide) leverages dual-action inhibition to modulate p38 MAPK signaling, empowering translational researchers to drive innovation in diabetes and neuroregeneration. This article integrates recent mechanistic insights, strategic guidance, and actionable protocol recommendations, advancing the field beyond conventional kinase inhibitor paradigms.
466 records 17/32 page Previous Next First page 上5页 1617181920 下5页 Last page